114 related articles for article (PubMed ID: 18020912)
21. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
Sun Z; Yang P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling in lymphoma diagnosis and research.
Chan WC
Croat Med J; 2005 Jun; 46(3):349-59. PubMed ID: 15861511
[TBL] [Abstract][Full Text] [Related]
23. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
24. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
Creighton CJ; Rae JM
Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
[TBL] [Abstract][Full Text] [Related]
25. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
26. Gene expression-driven diagnostics and pharmacogenomics in cancer.
Wang Y
Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
García-Escudero R; Paramio JM
Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
[TBL] [Abstract][Full Text] [Related]
28. A pathway-based approach to identify molecular biomarkers in cancer.
Stevenson M; Potti A
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S620-4. PubMed ID: 22048630
[TBL] [Abstract][Full Text] [Related]
29. Gene expression phenotypes of atherosclerosis.
Seo D; Wang T; Dressman H; Herderick EE; Iversen ES; Dong C; Vata K; Milano CA; Rigat F; Pittman J; Nevins JR; West M; Goldschmidt-Clermont PJ
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1922-7. PubMed ID: 15297278
[TBL] [Abstract][Full Text] [Related]
30. Three-gene prognostic classifier for early-stage non small-cell lung cancer.
Lau SK; Boutros PC; Pintilie M; Blackhall FH; Zhu CQ; Strumpf D; Johnston MR; Darling G; Keshavjee S; Waddell TK; Liu N; Lau D; Penn LZ; Shepherd FA; Jurisica I; Der SD; Tsao MS
J Clin Oncol; 2007 Dec; 25(35):5562-9. PubMed ID: 18065728
[TBL] [Abstract][Full Text] [Related]
31. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
32. Toward the individualization of lung cancer therapy.
Anguiano A; Nevins JR; Potti A
Cancer; 2008 Oct; 113(7 Suppl):1760-7. PubMed ID: 18800387
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
[TBL] [Abstract][Full Text] [Related]
35. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.
Tomida S; Takeuchi T; Shimada Y; Arima C; Matsuo K; Mitsudomi T; Yatabe Y; Takahashi T
J Clin Oncol; 2009 Jun; 27(17):2793-9. PubMed ID: 19414676
[TBL] [Abstract][Full Text] [Related]
36. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Lancashire LJ; Rees RC; Ball GR
Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
[TBL] [Abstract][Full Text] [Related]
37. Utilization of genomic signatures to direct use of primary chemotherapy.
Potti A; Nevins JR
Curr Opin Genet Dev; 2008 Feb; 18(1):62-7. PubMed ID: 18339540
[TBL] [Abstract][Full Text] [Related]
38. Prediction of lymph node metastasis using the combined criteria of helical CT and mRNA expression profiling for non-small cell lung cancer.
Chang JW; Yi CA; Son DS; Choi N; Lee J; Kim HK; Choi YS; Lee KS; Kim J
Lung Cancer; 2008 May; 60(2):264-70. PubMed ID: 18280003
[TBL] [Abstract][Full Text] [Related]
39. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
Nuyten DS; van de Vijver MJ
Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
[TBL] [Abstract][Full Text] [Related]
40. cDNA microarrays: identification of gene signatures and their application in clinical practice.
Magic Z; Radulovic S; Brankovic-Magic M
J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
